Interestingly, this study also showed that PGLYRP2 was negatively correlated to HDL-c and Apo-A1, but positively correlated to Apo-B/A1, indicating that PGLYRP2 serves as an indicator for SLE activity and a predictor for dyslipidemia. This evidence concerns the gene APOB and metabolic syndrome.